Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang YT, Wang D, Luo H, Xiao M, Zhou HS, Liu D, et al. Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes. Blood Cancer J. 2017;7:660.

Article  PubMed  PubMed Central  Google Scholar 

Fujimoto A, Ishida F, Izutsu K, Yamasaki S, Chihara D, Suzumiya J, et al. Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemia. Bone Marrow Transpl. 2021;56:347–56.

Article  Google Scholar 

Suzuki R, Suzumiya J, Nakamura S, Aoki S, Notoya A, Ozaki S, et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia. 2004;18:763–70.

Article  CAS  PubMed  Google Scholar 

Huang L, Liu D, Wang N, Ling S, Tang Y, Wu J, et al. Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia. Cell Res. 2018;28:172–86.

Article  PubMed  Google Scholar 

Dufva O, Kankainen M, Kelkka T, Sekiguchi N, Awad SA, Eldfors S, et al. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target. Nat Commun. 2018;9:1567.

Article  PubMed  PubMed Central  Google Scholar 

de Mel S, Hue SSS, Jeyasekharan AD, Chng WJ, Ng SB. Molecular pathogenic pathways in extranodal NK/T cell lymphoma. J Hematol Oncol. 2019;12:33.

Article  PubMed  PubMed Central  Google Scholar 

Kameda K, Yanagiya R, Miyatake Y, Carreras J, Higuchi H, Murayama H, et al. The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis. Blood. 2023;142:352–64.

CAS  PubMed  Google Scholar 

Ogama Y, Kumagai Y, Komatsu N, Araki M, Masubuchi N, Akiyoshi H, et al. Phase 1 clinical trial of PPMX-T003, a novel human monoclonal antibody specific for transferrin receptor 1, to evaluate its safety, pharmacokinetics, and pharmacodynamics. Clin Pharm Drug Dev. 2023;12:579–87.

Article  CAS  Google Scholar 

Andreini C, Putignano V, Rosato A, Banci L. The human iron-proteome. Metallomics. 2018;10:1223–31.

Article  CAS  PubMed  Google Scholar 

Pham LT, Peng H, Ueno M, Kohno S, Kasada A, Hosomichi K, et al. RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia. Biochem Biophys Res Commun. 2022;621:74–9.

Article  CAS  PubMed  Google Scholar 

Lifschitz S, Haeusler EH, Catanho M, Miranda AB, de Armas EM, de Heine A, et al. Bio-strings: a relational database data-type for dealing with large biosequences. BioTech (Basel). 2022;11:31.

Article  CAS  PubMed  Google Scholar 

Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019;47:e47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lawrence M, Huber W, Pagès H, Aboyoun P, Carlson M, Gentleman R, et al. Software for computing and annotating genomic ranges. PLoS Comput Biol. 2013;9:e1003118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 2014;15:554.

Article  PubMed  PubMed Central  Google Scholar 

Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kovaka S, Zimin AV, Pertea GM, Razaghi R, Salzberg SL, Pertea M. Transcriptome assembly from long-read RNA-seq alignments with StringTie2. Genome Biol. 2019;20:278.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313:1929–35.

Article  CAS  PubMed  Google Scholar 

Ushijima M, Mashima T, Tomida A, Dan S, Saito S, Furuno A, et al. Development of a gene expression database and related analysis programs for evaluation of anticancer compounds. Cancer Sci. 2013;104:360–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mashima T, Ushijima M, Matsuura M, Tsukahara S, Kunimasa K, Furuno A, et al. Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation. Cancer Sci. 2015;106:909–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2:100141.

CAS  PubMed  Google Scholar 

Shimizu T, Nakamura T, Inaba H, Iwasa H, Maruyama J, Arimoto-Matsuzaki K, et al. The RAS-interacting chaperone UNC119 drives the RASSF6–MDM2–p53 axis and antagonizes RAS-mediated malignant transformation. J Biol Chem. 2020;295:11214–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo W, Brouwer C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29:1830–1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Novita Sari I, Setiawan T, Seock Kim K, Toni Wijaya Y, Won Cho K, Young Kwon H. Metabolism and function of polyamines in cancer progression. Cancer Lett. 2021;519:91–104.

Article  CAS  PubMed  Google Scholar 

Kanai Y. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharm Ther. 2022;230:107964.

Article  CAS  Google Scholar 

Xu Q, Liu Y, Sun W, Song T, Jiang X, Zeng K, et al. Blockade LAT1 mediates methionine metabolism to overcome oxaliplatin resistance under hypoxia in renal cell carcinoma. Cancers (Basel). 2022;14:2551.

Article  CAS  PubMed  Google Scholar 

Kanai Y, Hediger MA. The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflug Arch. 2004;447:469–79.

Article  CAS  Google Scholar 

Okunushi K, Furihata T, Morio H, Muto Y, Higuchi K, Kaneko M, et al. JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 function. J Pharm Sci. 2020;144:16–22.

Article  CAS  Google Scholar 

Wang L, Li X, Mu Y, Lu C, Tang S, Lu K, et al. The iron chelator desferrioxamine synergizes with chemotherapy for cancer treatment. J Trace Elem Med Biol. 2019;56:131–8.

Article  CAS  PubMed  Google Scholar 

Kim JL, Lee DH, Na YJ, Kim BR, Jeong YA, Lee SI, et al. Iron chelator-induced apoptosis via the ER stress pathway i